Rocket Lab’s Biggest Breakthrough Has Nothing to Do With Neutron

For a while now, the biggest debate around Rocket Lab (RKLB) has been about when its new Neutron rocket will finally fly. The bull case, though, was that the company was much broader than that. They argued that Rocket Lab had quietly become a full-stack company, one that earns across launch, satellites, and defense. In their opinion, this made Rocket Lab meaningfully different from a startup betting everything on a single rocket. This quarter backed that view up.

Revenue hit a record, climbing 62% from a year ago, and the backlog also increased to an all-time high of $2.36 billion. But what’s interesting is that Neutron wasn’t behind this performance, since it hasn’t even launched yet. The growth came from the Space Systems business and new defense and government contracts. 

The Neutron Timing Isn’t the Real Story

Most of the attention went to management’s cautious tone on Neutron’s first launch. Investors worried that the timeline could slip into 2027. RKLB stock dipped after the report before recovering over the following days. But that reaction misses the point of the thesis. Neutron was the upside for Rocket Lab, not the foundation. 

If the company can post record numbers with its biggest future product still on the ground, then Neutron going operational only adds to a business that is already growing fast. The market often reacts as though the company’s survival depends on Neutron alone. But it keeps proving that it can grow with or without a launch date on the calendar, which makes me feel the bulls looking at the broader picture may have a point. 

About Rocket Lab Stock

Rocket Lab Corporation is a space company that provides rocket launch services and builds spacecraft, satellites, and related space systems for commercial, government, and aerospace customers worldwide. It also designs, manufactures, and sells Electron, an orbital small launch vehicle for small spacecraft launch services, as well as develops Neutron launch vehicles for large constellation deployments. In addition, the company designs and manufactures a range of components and subsystems for its launch vehicles and spacecraft. Founded in 2006, the company is headquartered in Long Beach, California. 

Over the last year, Rocket Lab shares have significantly outperformed the broader market. RKLB stock gained around 89% compared with a 30% return from the iShares US Aerospace & Defense ETF (ITA). However, in the last three months, the company's stock has dipped roughly 33%. The recent decline suggests that investors may be taking a more cautious stance toward RKLB’s near-term growth prospects, particularly as the company works toward key milestones.

Rocket Lab’s valuation is extremely steep, but almost every number helps back it up. The forward GAAP price-to-earnings (P/E) isn’t meaningful, since the company isn’t profitable yet. The forward price-to-sales (P/S) ratio of 50.38x sits at a 69% premium to its 5-year average of 29.88x. This reflects the market pricing in a lot of future growth, not just what the company earns today. The EPS outlook is in line with the market’s expectations. Analysts foresee a 75% growth in 2026, which for a loss-making company means that the losses are expected to narrow. The projections then point to a sharp acceleration in earnings later in the decade, which lines up with the record backlog and steady contract wins. 

The balance sheet is also a clear strength. Rocket Lab holds $2.3 billion in cash against just $134 million in debt. That cushion matters, especially for a company like Rocket Lab that is still burning cash as it builds toward Neutron. For investors, the growth story and diversified backlog do well to justify the premium. But at 50x sales, the stock is priced for near-flawless execution, including a successful Neutron debut. 

Rocket Lab Advances Iridium Deal While Guiding for Strong Q3 Growth

Rocket Lab Corporation reported its second-quarter fiscal 2026 earnings on Aug. 10. RKLB reported revenue of $234.06 million, up 62% year-over-year (YoY). The Space Systems segment delivered $189.5 million while the Launch Services segment generated revenue of $44.6 million. The earnings per share came in at -$0.08, worse than the -$0.06 loss analysts expected. However, GAAP gross margin was 36.1%, above guidance of 33% to 35%, while non-GAAP gross margin was 41.5%, above guidance. The company’s non-GAAP operating expenses were $115.7 million, and cash, equivalents, restricted cash, and marketable securities stood at about $2.4 billion at quarter end. 

Looking forward, the company expects revenue of $250 million to $265 million for the third quarter. Management guided for a GAAP gross margin of 29% to 31% and a non-GAAP gross margin of 35% to 37%. Operating expenses are expected to rise to $143 million to $149 million on a GAAP basis, mainly because of Neutron development and first-flight spending. Free cash flow is expected to remain negative. Moreover, the company also pointed to a growing backlog, strong government demand, and continued expansion in Europe through Rocket Lab Germany. 

What Do Analysts Expect for RKLB Stock?

On Aug. 11, Cantor Fitzgerald raised the firm’s price target on RKLB stock to $122 from $96 and kept an “Overweight” rating. The upward price target revision followed the company’s second-quarter results. The firm said Rocket Lab’s strong second-quarter results, which included record revenue and continued progress toward the planned Neutron rocket launch in the fourth quarter of 2026. Moreover, the analysts believe Iridium acquisitions could significantly expand the company’s market opportunity and strengthen its position as a company that offers a full range of space services. In contrast to Cantor Fitzgerald, Piper Sandler analyst Alexander Potter reiterated a “Hold” rating with a price target of $83.

Based on 18 analysts covering RKLB stock, it holds a consensus “Strong Buy” rating. The analysts' mean price target of $114.23 reflects a 38% upside from the current levels. RKLB currently trades near its lower price target of $77.